Replies to post #111833 on Sunshine Biopharma Inc (SBFM)

[hssbwwmp]

SBFM "estimates that it will take approximately 18 to 24 months from start to finish. Following successful completion of Phase I clinical trials, it is likely that we will be required to make Adva-27a available to patients under the “compassionate-use” guidelines."

SBFM said this about 7 months ago so they are down to 11-17 months which is why we should get a substantial update by early 2023 which takes off another 4-5 months of this timeline making it 6-12 months.

I'm holding and accumulating a bit more to see where this goes in 2023. And this is just based on the Cancer treatment becoming available to patients in late 2023.